Mechanisms of Axon Degeneration

The mechanisms of axonal degeneration are still poorly understood, but studies in animal models have pointed to specific cellular and molecular mechanisms that may be responsible. The degeneration of axons in the CNS has been found to be characteristic of many neurodegenerative diseases. Discover the latest research on the mechanisms of axon degeneration here.

September 15, 2021

Melatonin supplementation in the subacute phase after ischemia alleviates postischemic sleep disturbances in rats.

Brain and Behavior
Shu-Mei HaoMei-Hong Qiu
September 14, 2021
Review

The emerging role of miRNA-132/212 cluster in neurologic and cardiovascular diseases: Neuroprotective role in cells with prolonged longevity.

Mechanisms of Ageing and Development
Rachid El FatimyLuc Rochette
September 12, 2021
Preprint
Open Access

Activation of the CaMKII-Sarm1-ASK1 MAP kinase pathway protects against axon degeneration caused by loss of mitochondria

BioRxiv : the Preprint Server for Biology
C. DingMarc Hammarlund
September 12, 2021
Preprint
Open Access

The Drosophila TMEM184B ortholog Tmep ensures proper locomotion by restraining ectopic firing at the neuromuscular junction

BioRxiv : the Preprint Server for Biology
T. S. ChoMartha Ruth Chase Bhattacharya
September 11, 2021

A pathological perspective to painful inguinal hernia: Report of two cases.

International Journal of Surgery Case Reports
Masato NaritaTakashi Yamaguchi
September 9, 2021

A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis.

Nature
Martina AbsintaDaniel S Reich
September 9, 2021

Imaging of retina cellular and subcellular structures using ptychographic hard X-ray tomography.

Journal of Cell Science
V PanneelsG Schertler
September 7, 2021
Review

Visual fields and optical coherence tomography (OCT) in neuro-ophthalmology: Structure-function correlation.

Journal of the Neurological Sciences
Laura Donaldson, Edward Margolin
September 3, 2021
Preprint
Open Access

Glial TGFβ activity promotes axon survival in peripheral nerves

BioRxiv : the Preprint Server for Biology
A. LassetterMarc Freeman
September 2, 2021
Review

GDNF to the rescue: GDNF delivery effects on motor neurons and nerves, and muscle re-innervation after peripheral nerve injuries.

Neural Regeneration Research
Alberto F Cintron-ColonJohn M Spitsbergen
August 27, 2021
Review
Open Access

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer's and Parkinson's Diseases.

International Journal of Molecular Sciences
Keelan Jagaran, Moganavelli Singh
August 27, 2021
Review
Open Access

The Pathogenesis and Therapeutic Approaches of Diabetic Neuropathy in the Retina.

International Journal of Molecular Sciences
Toshiyuki Oshitari
August 27, 2021
Open Access

Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats.

International Journal of Molecular Sciences
Edina SzaboTamas Atlasz
August 27, 2021
Review
Open Access

Plasticity of the Injured Spinal Cord.

Cells
Nicolas Guérout
August 27, 2021
Review
Open Access

Targeting the NLRP3 Inflammasome in Glaucoma.

Biomolecules
Sophie CoyleVictoria McGilligan

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/mechanisms-of-axon-degeneration/f6d0821b-8c39-4d7a-91c0-8c3d769d7f16